And the Johnson & Johnson vaccine has not been reported to cause heart inflammation, a rare side effect impacting young men who received the Pfizer and Moderna vaccines. Based on all available data to date, the rare side effects that come with the Johnson & Johnson vaccine have not occurred in recipients of other authorized COVID-19 vaccines. Side effects from any of the vaccines authorized in the United States have been rare, and they are different depending on the vaccine. It’s good to have as much information as possible when making decisions. But like all big decisions, it’s yours to make. Plus, the vaccine is our greatest hope for ending the pandemic. The COVID-19 vaccines are a proven way to avoid serious illness and hospitalization from the virus. But the side effect has also been seen in men. Most people who developed TTS blood clots were women between 18 and 49. Most instances of GBS identified in the federal database were seen in males ages 50 and older. Who is at risk?Įxperts aren’t sure who, specifically, is at higher risk of developing GBS or TTS as a vaccine side effect. After a thorough review of all available vaccine data, the CDC and FDA have concluded that the Johnson & Johnson vaccine’s known benefits outweigh its known and potential risks. The pause came out of an abundance of caution after a small number of people who received the Johnson & Johnson vaccine developed Thrombosis with Thrombocytopenia syndrome (TTS), a blood-clotting disorder. Food and Drug Administration (FDA) and CDC paused the Johnson & Johnson vaccine. This isn’t the first warning to surface for the Johnson & Johnson vaccine. Most people with GBS fully recover, though some patients will experience lingering effects.Īs most hospitalizations and deaths linked to COVID are occurring among unvaccinated people, the Centers for Disease Control and Prevention (CDC) states that the benefits of the Johnson & Johnson vaccine outweigh the risks from the vaccine. If GBS progresses, muscle weakness can evolve into paralysis. It most commonly begins with tingling and weakness in the feet and legs, spreading to the upper body. GBS is a rare condition in which the body’s immune system attacks nerve cells. The federal government database has identified 100 suspected cases of Guillain-Barre syndrome (GBS) among the 12.8 million who received the Johnson & Johnson vaccine.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |